-
-
-
B607976-25mgbefetupitant.
-
-
-
-
B126780-10mgBelinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM, with activity demonstrated in cisplatin-resistant tumors.A novel HDAC inhibitor.
-
B126780-250mgBelinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM, with activity demonstrated in cisplatin-resistant tumors.A novel HDAC inhibitor.
-
B126780-50mgBelinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM, with activity demonstrated in cisplatin-resistant tumors.A novel HDAC inhibitor.
-
B414037-100mgInformationBelizatinib (TSR-011) is a potent inhibitor ofALK(IC50=0.7 nM) andtropomyosin receptor kinase (TRK)(IC50 values less than 3 nM for TRK A, B, and C). "TargetsTrkA : TrkB : TrkC : TrkA : TrkB 28040,:In vitroTSR-011 has high affinity for"
-
B414037-25mgInformationBelizatinib (TSR-011) is a potent inhibitor ofALK(IC50=0.7 nM) andtropomyosin receptor kinase (TRK)(IC50 values less than 3 nM for TRK A, B, and C). "TargetsTrkA : TrkB : TrkC : TrkA : TrkB 28040,:In vitroTSR-011 has high affinity for"
-
B414037-5mgInformationBelizatinib (TSR-011) is a potent inhibitor ofALK(IC50=0.7 nM) andtropomyosin receptor kinase (TRK)(IC50 values less than 3 nM for TRK A, B, and C). "TargetsTrkA : TrkB : TrkC : TrkA : TrkB 28040,:In vitroTSR-011 has high affinity for"